Avidity BiosciencesRNAM
13F holders, Q1 2026 (March 31)1holders −343
0new positions
334sold out
$29.52avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Avidity Biosciences Inc. (RNAM) in their 13F filings, down 343 from Q4 2025. 0 opened new positions and 334 sold out. The largest holder was Corsicana & Co. ($236K).
- Company
- Avidity Biosciences Inc.
- CUSIP
- 05370A108
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 334 | $9.2B |
All 13F filers, Q4 2025 → Q1 2026: 128,228,292 shares sold, net −128,228,292 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Corsicana & Co. | 0.15% | No change | 8,000 | $236K |
"% of holder's portfolio" is RNAM's weight in each manager's 13F, not the share of Avidity Biosciences Inc. the manager owns.